Cargando…
Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse a...
Autores principales: | Larsson, Per-Göran, Stray-Pedersen, Babill, Ryttig, Kjeld R, Larsen, Stig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225869/ https://www.ncbi.nlm.nih.gov/pubmed/18197974 http://dx.doi.org/10.1186/1472-6874-8-3 |
Ejemplares similares
-
Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial
por: Bradshaw, Catriona S., et al.
Publicado: (2012) -
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis
por: Marcotte, Harold, et al.
Publicado: (2019) -
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection
por: Pendharkar, Sonal, et al.
Publicado: (2015) -
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses
por: Larsson, Per-Göran, et al.
Publicado: (2011) -
Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk
por: Armstrong, Eric, et al.
Publicado: (2021)